Breaking News, Collaborations & Alliances

Orchard Inks Mfg. Agreement with PCT Cell Therapy

PCT will provide GMP manufacturing services for Orchard’s lead product

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Orchard Therapeutics has entered a clinical manufacturing services agreement with PCT Cell Therapy Services, a provider of contract services for the development and manufacture of cell-based therapeutic and regenerative medicine products. PCT has previously provided a strategic manufacturing assessment (SMA) and manufacturing process development services to Orchard. PCT will provide GMP-compliant manufacturing services for Orchard’s lead product, OTL-101, an autologous ex-vivo gene therapy for t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters